Celyad Oncology Management
Management criteria checks 3/4
Celyad Oncology's CEO is Michel E. Lussier, appointed in Dec 2023, has a tenure of less than a year. total yearly compensation is €96.31K, comprised of 29.9% salary and 70.1% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth €44.13K. The average tenure of the management team and the board of directors is 1.9 years and 7.4 years respectively.
Key information
Michel E. Lussier
Chief executive officer
€96.3k
Total compensation
| CEO salary percentage | 29.9% |
| CEO tenure | less than a year |
| CEO ownership | 0.4% |
| Management average tenure | 1.9yrs |
| Board average tenure | 7.4yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €96k | €29k | -€8m |
| Sep 30 2023 | n/a | n/a | -€20m |
| Jun 30 2023 | n/a | n/a | -€31m |
| Mar 31 2023 | n/a | n/a | -€35m |
| Dec 31 2022 | €269k | €38k | -€41m |
| Sep 30 2022 | n/a | n/a | -€32m |
| Jun 30 2022 | n/a | n/a | -€26m |
| Mar 31 2022 | n/a | n/a | -€25m |
| Dec 31 2021 | €98k | n/a | -€27m |
| Sep 30 2021 | n/a | n/a | -€17m |
| Jun 30 2021 | n/a | n/a | -€15m |
| Mar 31 2021 | n/a | n/a | -€18m |
| Dec 31 2020 | €78k | n/a | -€17m |
| Sep 30 2020 | n/a | n/a | -€28m |
| Jun 30 2020 | n/a | n/a | -€29m |
| Mar 31 2020 | n/a | n/a | -€29m |
| Dec 31 2019 | €85k | n/a | -€29m |
| Sep 30 2019 | n/a | n/a | -€32m |
| Jun 30 2019 | n/a | n/a | -€35m |
| Mar 31 2019 | n/a | n/a | -€36m |
| Dec 31 2018 | €73k | n/a | -€37m |
| Sep 30 2018 | n/a | n/a | -€49m |
| Jun 30 2018 | n/a | n/a | -€60m |
| Mar 31 2018 | n/a | n/a | -€58m |
| Dec 31 2017 | €86k | n/a | -€56m |
Compensation vs Market: Michel E.'s total compensation ($USD104.48K) is below average for companies of similar size in the Belgian market ($USD414.62K).
Compensation vs Earnings: Michel E.'s compensation has been consistent with company performance over the past year.
CEO
Michel E. Lussier (68 yo)
less than a year
Tenure
€96,306
Compensation
Mr. Michel E. J. Lussier, MS, BME, MBA, has been Independent Director at Occlutech Holding AG since May 2021. He served as a Managing Director of Fjord Ventures LLC till October 2020. Mr. Lussier serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | less than a year | €96.31k | 0.35% € 44.1k | |
| Vice President of Finance & Administration | 1.9yrs | no data | no data | |
| Communications & Investor Relations Director | no data | no data | no data | |
| Head of Legal | 1.9yrs | no data | no data | |
| Head of Intellectual Property | 1.9yrs | no data | no data | |
| Head of R&D | 2yrs | no data | no data | |
| Corporate Secretary | no data | no data | no data |
1.9yrs
Average Tenure
48.5yo
Average Age
Experienced Management: CYAD's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 17.4yrs | €96.31k | 0.35% € 44.1k | |
| Independent Chairwoman of the Board | 7.4yrs | €101.10k | no data | |
| Non-Executive Director | 16.4yrs | €15.50k | 0.14% € 17.1k | |
| Member of Scientific Advisory Board | no data | €10.00k | no data | |
| Member of Scientific Advisory Board | 8.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.2yrs | no data | no data | |
| Independent Director | 4.1yrs | €49.50k | no data | |
| Independent Director | 4.1yrs | €69.50k | no data | |
| Non-Executive Director | 2.5yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 2.4yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.4yrs
Average Tenure
66yo
Average Age
Experienced Board: CYAD's board of directors are considered experienced (7.4 years average tenure).